Unknown

Dataset Information

0

Exploiting MET dysregulation in EGFR-addicted non-small-cell lung carcinoma: a further step toward personalized medicine.

ABSTRACT:

SUBMITTER: Di Noia V 

PROVIDER: S-EPMC6328682 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Induced pluripotent stem cells for defining Parkinsonian patient subtypes: a further step toward precision medicine.
| S-EPMC8530126 | biostudies-literature
Unknown Toward Personalized Medicine in Bronchiolitis.
| S-EPMC6580667 | biostudies-literature
Unknown Pharmacogenomics in osteoporosis: Steps toward personalized medicine.
| S-EPMC3513203 | biostudies-literature
Unknown Neurological Disease in Lupus: Toward a Personalized Medicine Approach.
| S-EPMC5997834 | biostudies-other
Unknown Pharmacogenomics of sickle cell disease: steps toward personalized medicine.
| S-EPMC5656342 | biostudies-literature
Unknown Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma.
| S-EPMC7038132 | biostudies-literature
Unknown Exploiting the complexity of the genome and transcriptome using pharmacogenomics towards personalized medicine.
| S-EPMC3091296 | biostudies-literature
Unknown Harnessing gemcitabine metabolism: a step towards personalized medicine for pancreatic cancer.
| S-EPMC3481558 | biostudies-other
Unknown Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine.
| S-EPMC3513204 | biostudies-literature
Unknown Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors: Small Steps Toward Personalized Medicine?
| S-EPMC6463228 | biostudies-literature